Website stats and analysis

HTTP/. Moved Temporarily Date: Mon, Jun :: GMT Server: Apache Expires: Thu, Nov :: GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=, pre-check= Pragma: no-cache location: /en Transfer-Encoding: chunked Content-Type: text/html; Acasti Pharma Inc. (ACST) Franais ...

2.48 Rating by Usitestat

acastipharma.com was registered 1 decade 6 years ago. It has a alexa rank of #4,525,068 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, acastipharma.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 194
Daily Pageviews: 388

Estimated Valuation

Income Per Day: $ 1.00
Estimated Worth: $ 240.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: 4,550
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 4,525,068
PageSpeed Score: 79 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

174.129.30.187

Hosted Country:

United States US

Location Latitude:

39.0395

Location Longitude:

-77.4918

Traffic Classification

Total Traffic: No Data
Direct Traffic: 31.22%
Referral Traffic: 12.35%
Search Traffic: 48.98%
Social Traffic: 7.45%
Mail Traffic: 0%
Display Traffic: 0%

Search Engine Results For acastipharma.com

Acasti Pharma Inc. (ACST)

- http://www.acastipharma.com/

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of...


Acasti Pharma, Inc. (ACST) Stock Price, News, Quote ...

- https://finance.yahoo.com/quote/ACST

Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing.


Acasti Pharma, Inc. (ACST) Company Profile & Facts - Yahoo ...

- https://finance.yahoo.com/quote/ACST/profile

Description. Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of...


ACST - Acasti Pharma Inc. • BioPharmCatalyst

- https://www.biopharmcatalyst.com/company/acst

LAVAL, Québec, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST, TSXV:ACST), announces the voting results for the matters listed...


Acasti Pharma Stock Loses a Wall Street Supporter | Nasdaq

- https://www.nasdaq.com/articles/acasti-pharma-stock-loses-a-wall-street-supporter-2020-09-01

Sep 01, 2020 · The week couldn’t have gotten off to a worse start for investors of Acasti Pharma (ACST). Shares cratered by a massive 65% in Monday’s trading following the...


Acasti Pharma Inc. (NASDAQ:ACST) Forecast to gain 380.95% ...

- https://marketingsentinel.com/2020/09/29/acasti-pharma-inc-nasdaqacst-forecast-to-gain-380-95-to-hit-consensus-price-target/

Sep 29, 2020 · Acasti Pharma Inc. (NASDAQ:ACST) has a beta value of 0 and has seen 2,977,302 shares traded in the last trading session. The company, currently valued at $19.3...


Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing ...

- https://www.globenewswire.com/news-release/2020/06/19/2050665/0/en/Acasti-Pharma-Receives-FDA-Response-to-TRILOGY-1-Briefing-Package.html

Jun 19, 2020 · About Acasti Pharma. Acasti is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the...


Acasti Pharma Reports Topline Triglyceride Results from ...

- https://www.globenewswire.com/news-release/2020/08/31/2086019/0/en/Acasti-Pharma-Reports-Topline-Triglyceride-Results-from-Phase-3-TRILOGY-2-Study-of-CaPre-in-Patients-with-Severe-Hypertriglyceridemia.html

Aug 31, 2020 · Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia CaPre achieved a 30.4%...


Acasti Pharma Inc (ACST) Quote | Morningstar

- https://www.morningstar.com/stocks/XNAS/ACST/quote

Acasti Pharma Inc is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition...


Acasti Pharma (Class A) - ACST - Stock Price & News | The ...

- https://www.fool.com/quote/nasdaq/acasti-pharma-class-a/acst/

Real time Acasti Pharma (Class A) (ACST) stock price quote, stock graph, news & analysis.


Acasti Pharma Inc. Stock Price (ACST) | Barron's

- https://www.barrons.com/quote/stock/us/xnas/acst

Oct 23, 2020 · View today's stock price, news and analysis for Acasti Pharma Inc. (ACST). Barron's also provides information on historical stock ratings, target prices, …


ACST Stock Forecast, Price & News (Acasti Pharma)

- https://www.marketbeat.com/stocks/NASDAQ/ACST/

5 analysts have issued 12-month price objectives for Acasti Pharma's shares. Their forecasts range from $0.50 to $7.00. On average, they anticipate Acasti Pharma's stock price...


ACST: Acasti Pharma Inc - Full Company Report - Zacks.com

- https://www.zacks.com/stock/research/ACST/company-reports

Sep 30, 2020 · Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid...


ACST Stock Price Quote & News - Acasti Pharma | Robinhood

- https://robinhood.com/stocks/ACST

View the real-time ACST price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read...


Acasti Pharma, Inc (ACST) Stock Analysis Buy and Sell ...

- https://www.trade-ideas.com/ticky/ticky.html?symbol=ACST

Acasti Pharma, Inc. SCoRE: 43 . Learn about the SCoRE. PRICE ACTION $0.1896. LAST PRICE - 06:33pm. ACST is trading at yesterday's close of $0.1896. Right now ACST is $0.0054...


Acasti Pharma Inc (ACST-X) Quote - The Globe and Mail

- https://www.theglobeandmail.com/investing/markets/stocks/ACST-X/

Acasti Pharma Inc is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition...


Acasti Pharma, Inc. - ACST - Stock Price Today - Zacks

- https://www.zacks.com/stock/quote/ACST

Oct 29, 2020 · Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid...


ACASTI PHARMA INC. (NASDAQ:ACST) Files An 8-K Other Events ...

- https://marketexclusive.com/acasti-pharma-inc-nasdaqacst-files-an-8-k-other-events/2020/09/

Sep 29, 2020 · Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical...


What Makes Acasti (ACST) a New Buy Stock | Nasdaq

- https://www.nasdaq.com/articles/what-makes-acasti-acst-a-new-buy-stock-2020-08-14

Aug 14, 2020 · Acasti Pharma (ACST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in …


ACST:NASDAQ CM Stock Quote - Acasti Pharma Inc - Bloomberg ...

- https://www.bloomberg.com/quote/ACST:US

Stock analysis for Acasti Pharma Inc (ACST:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Page Resources Breakdown

Homepage Links Analysis

Acasti Pharma Inc. (ACST)
Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the…

Website Inpage Analysis

H1 Headings: 1 H2 Headings: 1
H3 Headings: 3 H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 4
Google Adsense: Not Applicable Google Analytics: Not Applicable

Websites Hosted on Same IP (i.e. 174.129.30.187)

Bristow Group Inc. (VTOL)

- bristowgroup.com

Bristow provides safe, reliable and efficient helicopter services for offshore oil and gas transportation, SAR and government and civil organizations.

  1,136,615   $ 1,200.00

Rigel Pharmaceuticals, Inc. (RIGL)

- rigel.com

  888,961   $ 1,440.00

Brunswick Corporation (BC)

- brunswick.com

Brunswick Corporation, a world-class leader in the marine industry, turns innovation into reality via renowned marine brands.

  335,184   $ 27,540.00

Resonant Inc. (RESN)

- resonant.com

  602,587   $ 2,160.00

Global Eagle Entertainment Inc. (GEENQ)

- globaleagle.com

  169,940   $ 73,800.00

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Mon, 24 Jun 2019 11:03:36 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 3896
Content-Type: text/html; charset=UTF-8

Domain Information

Domain Registrar: GoDaddy.com, LLC
Registration Date: 2008-08-01 1 decade 6 years 1 month ago
Last Modified: 2015-05-19 9 years 4 months 5 days ago

Domain Nameserver Information

Host IP Address Country
ns77.domaincontrol.com 97.74.108.49 United States United States
ns78.domaincontrol.com 173.201.76.49 United States United States

DNS Record Analysis

Host Type TTL Extra
acastipharma.com A 591 IP: 174.129.30.187
acastipharma.com NS 3600 Target: ns78.domaincontrol.com
acastipharma.com NS 3600 Target: ns77.domaincontrol.com
acastipharma.com SOA 3600 MNAME: ns77.domaincontrol.com
RNAME: dns.jomax.net
Serial: 2019050600
Refresh: 28800
Retry: 7200
Expire: 604800
acastipharma.com MX 3600 Priority: 5
Target: mail-gateway.acastipharma.com
acastipharma.com TXT 3600 TXT:
google-site-verification=BIrGcd6A0i09lbL
wKxEyPYacha4CRApqmmWEOJvQKa0
acastipharma.com TXT 3600 TXT: v=spf1 a mx
include:mail-gateway-1.neptunebiotech.co
m ~all
acastipharma.com TXT 3600 TXT: v=verifydomain MS=5983861

Top Organic Keyword

1. acasti
2. acasti pharma
3. acasti pharma sherbrooke
4. capre acasti trademarkia
5. a phase 3 study of capre in lowering very high triglycerides (trilogy 1) (trilogy 1)

Top Paid Keyword

Not Applicable

Full WHOIS Lookup

Domain Name: ACASTIPHARMA.COM
Registry Domain ID:
1511372729_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2015-05-19T13:44:23Z
Creation Date:
2008-07-31T18:52:17Z
Registry Expiry Date:
2020-07-31T18:52:17Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS77.DOMAINCONTROL.COM
Name Server:
NS78.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-06-24T11:03:34Z

Similarly Ranked Websites

Realities.io

- realities.io

4,525,095   $ 240.00

www.ojanelao.com/inicio | O Janelão

- ojanelao.com

4,525,200   $ 240.00

Startseite | Oligo

- oligo.de

Modulare Leuchtensysteme und elegante Einzelleuchten von Oligo bietet perfekte Lichtlösungen in LED- und Halogen-Technik für den Einsatz in privaten und öffentlichen Bereichen.

4,525,201   $ 240.00

Gymboree México - .:.

- gymboreeclases.mx

4,525,209   $ 240.00

Online Shop für Spielzeug, Mobiltelefone, Elektronik & Spiele -...

- xmen.ch

Bei xmen.ch finden Sie über 65'000 Produkte: Fernseher, Spielzeuge, Notebooks, Laptops, Mobiltelefone und Haushaltsgeräte zu günstigen Preisen - Schnelle Lieferung in die ganze...

4,525,242   $ 240.00